PAPER Wolfe KJ, Cyr DM
SEARCH RESULTS
331159 RESULTS
PAPER Prestia A, Boccardi M, Galluzzi S, Cavedo E, Adorni A, Soricelli A, Bonetti M, Geroldi C, Giannakopoulos P, Thompson P, Frisoni G
Hippocampal and amygdalar volume changes in elderly patients with Alzheimer's disease and schizophrenia.
Psychiatry Res. 2011 May 31;192(2):77-83. PubMed: 21458960PAPER Alagille D, Dacosta H, Baldwin RM, Tamagnan GD
2-Arylimidazo[2,1-b]benzothiazoles: a new family of amyloid binding agents with potential for PET and SPECT imaging of Alzheimer's brain.
Bioorg Med Chem Lett. 2011 May 15;21(10):2966-8. PubMed: 21458990PAPER Nakagawa K, Kiko T, Miyazawa T, Sookwong P, Tsuduki T, Satoh A
Amyloid β-induced erythrocytic damage and its attenuation by carotenoids.
FEBS Lett. 2011 Apr 20;585(8):1249-54. PubMed: 21459092PAPER Rockwood K, Walsh R, Martin E, Darvesh S
Potentially procholinergic effects of medications commonly used in older adults.
Am J Geriatr Pharmacother. 2011 Feb;9(1):80-7. PubMed: 21459311PAPER Stoub T, Barnes CA, Shah RC, Stebbins GT, Ferrari C, Detoledo-Morrell L
Age-related changes in the mesial temporal lobe: the parahippocampal white matter region.
Neurobiol Aging. 2011 Apr 1; PubMed: 21459484PAPER Futakawa S, Nara K, Miyajima M, Kuno A, Ito H, Kaji H, Shirotani K, Honda T, Tohyama Y, Hoshi K, Hanzawa Y, Kitazume S, Imamaki R, Furukawa K, Tasaki K, Arai H, Yuasa T, Abe M, Narimatsu H, Hashimoto Y
A unique N-glycan on human transferrin in CSF: a possible biomarker for iNPH.
Neurobiol Aging. 2011 Apr 1; PubMed: 21459485PAPER Tasso B, Catto M, Nicolotti O, Novelli F, Tonelli M, Giangreco I, Pisani L, Sparatore A, Boido V, Carotti A, Sparatore F
Quinolizidinyl derivatives of bi- and tricyclic systems as potent inhibitors of acetyl- and butyrylcholinesterase with potential in Alzheimer's disease.
Eur J Med Chem. 2011 Jun;46(6):2170-84. PubMed: 21459491PAPER Verny M
[Circumstances of hospitalization of elderly affected by Alzheimer's disease].
Rev Med Interne. 2011 Jun;32 Suppl 1:S14-6. PubMed: 21459494PAPER Manczak M, Calkins MJ, Reddy PH
Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage.
Hum Mol Genet. 2011 Jul 1;20(13):2495-509. PubMed: 21459773PAPER Mulder J, Zilberter M, Pasquaré SJ, Alpár A, Schulte G, Ferreira SG, Köfalvi A, Martín-Moreno AM, Keimpema E, Tanila H, Watanabe M, Mackie K, Hortobágyi T, De Ceballos ML, Harkany T
Molecular reorganization of endocannabinoid signalling in Alzheimer's disease.
Brain. 2011 Apr;134(Pt 4):1041-60. PubMed: 21459826PAPER Avdesh A, Wong P, Martins RN, Martin-Iverson MT
Memory function in a mouse genetic model of Alzheimer's disease.
J Alzheimers Dis. 2011;25(3):433-44. PubMed: 21460433PAPER Seppälä TT, Koivisto AM, Hartikainen P, Helisalmi S, Soininen H, Herukka SK
Longitudinal changes of CSF biomarkers in Alzheimer's disease.
J Alzheimers Dis. 2011;25(4):583-94. PubMed: 21460434PAPER D'Alton S, George DR
Changing perspectives on Alzheimer's disease: thinking outside the amyloid box.
J Alzheimers Dis. 2011;25(4):571-81. PubMed: 21460435PAPER Gadad BS, Britton GB, Rao KS
Targeting oligomers in neurodegenerative disorders: lessons from α-synuclein, tau, and amyloid-β peptide.
J Alzheimers Dis. 2011;24 Suppl 2:223-32. PubMed: 21460436Current Filters
No filters selected